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Introduction
The World Health Organization (WHO) estimates that 
about 4.3 million stillbirths and 3.4 million deaths occur 
during the first week of  life annually, with 98% of  these 
deaths occurring in developing countries.1 Deaths occurring 
in the first days and weeks of  life most often result from 
events in utero and during birth, rather than as consequences 
of  the external environment into which the baby is born, 
and thus are closely associated with the mother’s health and 
healthcare.
Hypertension in pregnancy (HIP) constitutes a major health 
burden in the obstetric population, as it is one of  the leading 
causes of  maternal and perinatal morbidity and mortality.2 
HIP can be defined as diastolic blood pressure of  at least 90 
mmHg, a systolic blood pressure of  at least 140 mmHg, a rise 
in diastolic blood pressure by at least 15 mmHg, or a rise by 
30 mmHg in systolic blood pressure in a pregnant woman on 
at least two different occasions at least 6 hours apart.3,4 HIP 
disorders complicate about 12% to 22% of  pregnancies.2 
In the United States, pregnancy-related deaths have been 
found to be 2 to 3 times more common in blacks than in 
white women with HIP, accounting for 16% of  the deaths.5 
The American College of  Obstetricians and Gynecologists, 
and the United Nations Organization recognise four 
categories of  HIP. These include chronic hypertension, 
gestational hypertension, preeclampsia/eclampsia, and 
superimposed preeclampsia/eclampsia (a condition defined 
as chronic hypertension complicated by preeclampsia/
eclampsia).1,2,6 Haemolysis, elevated liver enzymes and low 
platelets (HELLP) syndrome is considered a complication 
of  severe preeclampsia. Preeclampsia can be mild or severe. 
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Hypertension is said to be mild when the blood pressures are 
less than 160/110mmHg, whereas it is severe when blood 
pressures are above the 160/110mmHg threshold.4
Hypertension gives rise to a range of  maternal and foetal 
complications. The maternal complications are a result of  the 
high blood pressure itself, and the effects of  the hypertension 
on different organs. These complications include 
thrombocytopenia, disseminated intravascular coagulation 
(DIC), placental abruption, oliguria, renal failure, pulmonary 
oedema, permanent visual disturbances, intracranial 
haemorrhage and stroke, hepatic failure, and cardiovascular 
collapse. The foetal and neonatal complications basically 
arise from hypoxia and acute or chronic uteroplacental 
insufficiency.7,8,9,10 These complications include a range of  
haematological derangements, such as polycythaemia,7,8 
which is 12.6 times more prevalent among children born 
to mothers with HIP than in the general population;8 
neutropenia, which is also observed to be prolonged in this 
group of  neonates with attendant higher risk of  nosocomial 
infections;9 thrombocytopenia, occurring in as many as 22% 
of  these infants;10 and some coagulation disorders.11 Other 
foetal and neonatal complications are intrauterine growth 
restriction, prematurity, and bronchopulmonary dysplasia.
There is a dearth of  published data on haematological findings 
in neonates (infants within the first 28 days of  life) in Nigeria, 
despite the high prevalence of  maternal hypertension and 
perinatal mortality in our population,5 as well as the observed 
racial variations in blood counts,12,13 wherein black individuals 
are known to have lower neutrophil and platelet counts. The 
purpose of  this study was to determine the haematological 
values among neonates of  hypertensive mothers, with 
particular reference to their haemogram.
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Abstract
Background
Hypertension in pregnancy is a leading cause of  maternal and neonatal morbidity and mortality. This study aimed to compare the hematological 
parameters in neonates of  hypertensive mothers with those of  normotensive mothers, and also to compare the incidence of  polycythaemia, neutropenia 
and thrombocytopenia in both groups.
Methods
This was a hospital-based case control study. Three milliliters of  cord blood from neonates of  women with hypertension in pregnancy and those of  
normotensive pregnant women were sampled for haemogram parameters using a 3-part autoanalyser. Haematocrit and white blood cell differentials 
were done manually. Data were analysed using SPSS version 16. 
Results
A total of  200 neonates were recruited, comprising 100 neonates of  mothers with hypertensive disorders of  pregnancy and 100 neonates of  normotensive 
mothers. The mean haematocrit was significantly higher in neonates of  hypertensive mothers than those of  normotensive mothers. The neutrophil and 
platelet counts of  neonates of  hypertensive mothers were significantly lower than those of  normotensive mothers. The incidences of  polycythaemia, 
neutropenia, and thrombocytopenia were found to be 8%, 15%, and 38% among neonates of  hypertensive mothers and 0%, 2%, and 8% among 
neonates of  normotensive mothers, respectively. These incidences were significantly different between the groups.
Conclusions
There was a positive association between hypertension in pregnancy and neonatal polycythaemia, neutropenia, and thrombocytopenia. Haematological 
parameters of  neonates of  mothers with hypertension in pregnancy should be properly evaluated and monitored to reduce the chances of  developing 
complications associated with these abnormalities.
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age (GA)
• Preeclampsia/eclampsia: BP ≥ 140/90 mmHg after 
20 weeks GA, with proteinuria of  ≥ 300mg/24 hours, 
or ≥ 1+ on dipstick ± seizures
• Chronic hypertension with superimposed 
preeclampsia: BP ≥ 140/90 mmHg before 20 weeks 
GA but with new onset proteinuria (≥ 300mg/24hours 
or ≥ 1+ dipstick) occurring after 20 weeks GA
• Gestational hypertension: BP ≥ 140/90 mmHg for 
the first time after 20 weeks GA during pregnancy and 
without proteinuria
• Cases were considered to have mild HIP if  BP 
was ≤ 160/110mmHg, and severe HIP if  BP was > 
160/110mmHg
All cases and controls had their cord blood sampled 
immediately after delivery. This was done following double-
clamping and cutting the cord in between the clamps, 
then inserting the syringe at the placental end of  the cord 
proximally and collecting about 4 mL of  cord blood. The 
cord blood was analysed for full blood count, including 
haemoglobin concentration, white blood cell count, and 
platelet count, using the 3-part autoanalyser (Sysmex model 
Kx 21N®). Haematocrit was done manually using plain 
capillary tubes (75 mm long with 1 mm bore and 0.2 mm 
to 0.25 mm wall thickness), as it is recommended that only 
haematocrit values determined by microcentrifugation or 
spun technique be used to screen infants with suspected 
polycythaemia.14 Peripheral blood film analysis was done to 
confirm white blood cell counts, carry out differential white 
blood cell counts, calculate corrected white blood cell counts 
(where necessary), and confirm platelet counts. All tests were 
carried out in duplicate and the mean of  the two test taken.
Neonates were considered polycythaemic if  their haematocrit 
was 65% or greater, neutropenic if  their absolute neutrophil 
count was less than 1.5 × 109/L; and thrombocytopenic if  
their platelet count was less than 90 × 109/L. 
Statistical analysis 
Data were analysed using the Statistical Package for Social 
Sciences (SPSS) software (version 16). Means, standard 
deviations (SD), and percentages were calculated for the 
various measurements and variables obtained during 
data collection. Student’s t-test and analysis of  variance 
(ANOVA) were used, as appropriate, to compare the means 
of  numerical parameters, while Chi-square and Fisher’s 
Exact test were used, as appropriate, to compare qualitative 
parameters between the groups. A P-value of  0.05 or less 
was considered significant.
Ethical considerations
Ethical approval for this study was obtained from the 
University of  Port Harcourt Research Ethical Committee, 
and it was carried out in accordance with the Declaration of  
Helsinki. Informed consent was obtained from the parents 
or caregivers of  the neonates.
Results
The mean age, parity, and gravidity of  women with 
HIP and those of  the controls are presented in Table 1. 
Likewise, the mean GA at diagnosis, family history of  
hypertension, hypertension in previous pregnancies, severity 
of  hypertension, and mode of  delivery are shown in Table 1.
Mothers who had live births were recruited for both groups; 
the cases had 53 males and 47 females, while the controls 
had 45 males and 55 females. The average birthweight of  
Methods
Study site and design
This was a hospital-based case control study, conducted at 
the University of  Port Harcourt Teaching Hospital (UPTH), 
Rivers State, Nigeria, from July 2013 to December 2013.
Study population, sample size, and recruitment
A total of  200 study participants, who were recruited from 
the labour wards or theatre were placed in two groups: the 
case group, which was comprised of  100 neonates delivered 
to pregnant women with hypertension in pregnancy (HIP); 
and the control group, made up of  100 neonates delivered to 
normotensive pregnant women, matched for gestational age 
and parity with the case group. They were recruited using 
a systematic random sampling method through the labour 
wards and theatres. The obstetrics unit of  the hospital 
delivers about two new hypertensive mothers daily, giving a 
total of  10 cases in a week.
The study was designed to be carried out over a period of  6 
months, during which about 240 mothers with hypertension 
were expected to deliver.
Therefore, using the formulae N/n = k 
Where: N = total number of  cases seen; n = sample size for 
cases; k = interval 
k = 240/100 = 2.4 ≈ 2 
Following this calculation, the number 1 was randomly 
chosen (between 1 and 2) as a daily starting point. Starting 
with the first patient seen each day, every other patient seen 
that satisfied the inclusion criteria was recruited. Mothers 
who met the selection criteria for the control group were 
selected the same way. Demographic data, obstetric history, 
data on hypertensive disorders of  pregnancy, and birth 
outcomes were documented from the case notes, as well 
as using a structured questionnaire. Those who required 
emergency caesarean sections were followed to the theatre 
for further data and sample collection. The newborns of  all 
cases and controls were sampled for haematological analysis.
Neonates born from mothers who were diagnosed and 
managed for HIP, as well as full-term apparently healthy 
neonates born to normotensive mothers, without maternal 
complications, matched for gestational age with the test 
group, served as the case and control groups, respectively.
Inclusion and exclusion criteria
Subjects were excluded at the point of  recruitment when 
they checked into the labour wards or theatre if  they had 
any of  the following features: multiple pregnancies, diabetes 
mellitus, renal or heart diseases, or a history of  chronic 
pulmonary disease or smoking. Others were excluded 
during or after labour if  they had twin-twin transfusion 
syndrome, delayed cord clamping, delayed labour below 
the level of  mother’s introitus, cord milking, babies born to 
mothers whose pregnancies were complicated by any other 
risk factors for increase in maternal or foetal morbidity and 
mortality, such as Rh incompatibility, and babies born with 
congenital malformations and birth asphyxia.
Postpartum data collection
Details of  labour, mode of  delivery, and presence of  
complications were obtained for each neonate, as well as the 
sex, date and time of  birth, and Apgar score.
Diagnostic considerations
Mothers were diagnosed with HIP based on the following:
• Chronic hypertension: blood pressrure (BP) ≥ 
140/90 mmHg, diagnosed before 20 weeks gestational 
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Table 1: Demographic characteristics, hypertension history, mode of delivery, and 
birth outcome
Variables
Subjects  with 
hypertension in 
pregnancy 




(mean ± SD) 
n = 100
P-value
Age (years) 31.7 ± 4.1 30.7 ± 5.4 0.109
Parity 1.5 ± 1.2 1.7 ± 1.4 0.339
Gravidity 3.6 ± 1.7 3.1 ± 1.6 0.053
GA at diagnosis (weeks) 32.9 ± 7.5 NA NA
GA at delivery (weeks) 37.8 ± 3.1 38.6 ± 2.1 0.019
Frequency (%) Frequency (%)
Positive family history of 
hypertension 35 (35.0) 28 (28.0) 0.287
Diagnosis
Chronic hypertension 16 (16.0) NA NA
Gestational hypertension 28 (28.0) NA NA
Preeclampsia 46 (46.0) NA NA
Eclampsia 10 (10.0) NA NA
Previous history of 
hypertension in pregnancy 34 (34.0) 10 (10.0) < 0.001
Severity of hypertension
Mild 21 (21.0) NA NA
Severe 79 (79.0) NA NA
Number already on  
therapy 55 (55.0) NA NA
Mode of delivery
Spontaneous vertex 28 (28) 79 (79.0) < 0.001
Elective caesarean section 25 (25.0) 10 (10.0) < 0.001
Emergency caesarean section 47 (47.0) 11 (11.0) < 0.001
Birth outcome
Sex
Male 53 (53.0%) 45 (45.0%) 0.256
Female 47 (47.0%) 55 (55.0%) 0.256
Birthweight (kg) 2.98 ± 0.8 3.3 ± 0.5 0.005
SD = standard deviation; GA = gestational age; NA = not applicable
Table 1: Demographic characteristics, hypertension history, mode 
of delivery, and birth outcome
Table 2: Neonatal haematology results
Haematological indices
Neonates of women 
with hypertension in 
pregnancy 
(mean ± SD) 
n = 100
Neonates of normal 
pregnant women 
(mean ± SD) 
n = 100
P-value
Haematocrit (%) 51.1 ± 9.0 45.5 ± 7.5 < 0.001
Haemoglobin (g/dL) 16.6 ± 3.1 14.8 ± 2.3 < 0.001
WBC (× 109/L) 11.1 ± 5.2 10.6 ± 4.3 0.443
Corrected WBC (× 109/L) 10.2 ± 4.3 10.0 ± 4.1 0.847
Neutrophils (× 109/L) 4.5 ± 3.1 5.4 ± 2.7 0.033
Bands (× 109/L) 0.59 ± 0.05 0.53 ± 0.04 0.404
Metamyelocytes (× 109/L) 0.24 ± 0.03 0.22 ± 0.02 0.666
Myelocytes (× 109/L) 0.11 ± 0.02 0.11 ± 0.01 0.876
Promyelocytes (× 109/L) 0.04 ± 0.01 0.05 ± 0.01 0.463
Myeloblasts (× 109/L) 0.03 ± 0.01 0.03 ± 0.01 0.726
Eosinophils (× 109/L) 0.03 ± 0.01 0.03 ± 0.01 0.924
Basophils (× 109/L) 0.02 ± 0.00 0.01 ± 0.00 0.125
Lymphocytes (× 109/L) 4.3 ± 1.6 3.6 ± 2.0 0.006
Monocytes (× 109/L) 0.14 ± 0.03 0.08 ± 0.01 0.030
Platelets (× 109/L) 157 ± 106 212 ± 88 < 0.001
SD = standard deviation; WBC = white blood cells
Table 2: Neonatal haematology results
Table 3: Incidence of neonatal polycythaemia, neutropenia, and thrombocytopenia
Variables
Neonates of women 
with hypertension in 
pregnancy 
mean ± SD 
N = 100
Neonates of normal 
pregnant women 
mean ± SD 
N = 100
P-value
Polycythaemia 8 (8.0) 0 (0.0) 0.007
Neutropenia 15 (15.0) 2 (2.0) 0.002
Thrombocytopenia 38 (38.0) 8 (8.0) < 0.001
Table 3: Incidence of neonatal polycythaemia, neutropenia, and 
thrombocytopenia
Table 4: Mean haematocrits, absolute neturophil counts, and platelet counts among neonates born to mothers with different 


























Haematocrit (%) 53.0 ± 7.9 51.3 ± 10.4 50.6 ± 8.7 49.6 ± 9.2 0.77 51.1 ± 9.0 45.5 ± 7.5 < 0.001
Absolute neutrophil 
count (× 109/L) 3.8 ± 2.7 4.9 ± 4.2 4.4 ± 2.6 4.7 ± 3.4 0.74 4.5 ± 3.1 5.4 ± 2.7 0.03
Platelet count (× 109/L) 172.0 ± 112.5 157.8 ± 106.8 146.9 ± 96.0 178.3 ± 146.1 0.77 157 ± 106 212 ± 88 < 0.001
Table 4: Mean haematocrits, absolute neturophil counts, and platel t counts among neonates born to mothers with differ nt hypertensive 
disorders of pregnancy
Eight (8%) of  the babies delivered to women with HIP 
had polycythaemia, compared to zero among the controls 
(see Table 3). The haematocrit range in the polycythaemic 
neonates was 65% to 72%. Fifteen (15%) of  the cases had 
neutropenia, while 2 (2%) of  the controls had neutropenia. 
Thirty eight (38%) of  babies of  women with HIP had 
thrombocytopenia, compared to 8 (8%) of  the controls. Out 
of  the 38 neonates with thrombocytopenia in the case group, 
5% had both polycythaemia and thrombocytopenia, 6% had 
both neutropenia and thrombocytopenia, while one neonate 
had polycythaemia, neutropenia, and thrombocytopenia. 
Haematocrit, absolute neutrophil count, and platelet count 
did not differ significantly between babies delivered to 
women in the various subtypes of  hypertension in pregnancy 
(see Table 4).
babies delivered by women with HIP was 2.98 ± 0.8 kg, 
while that of  the controls was 3.3 ± 0.5 kg; this difference 
was statiscally significant (P = 0.05).
The haematologic parameters of  both groups were as 
presented in Table 2. The mean haematocrit and mean 
haemoglobin concentration of  babies delivered to women 
with HIP were significantly higher than those of  the 
controls. Similarly, the lymphocyte and monocyte counts 
were significantly higher in babies of  women with HIP but
the neutrophil and platelet counts were significantly lower. 
There was no significant difference in the other white blood 
cell differentials.
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platelet counts.13 This notwithstanding, it is possible to have 
some degree of  thrombocytopenia in neonates because of  
the limited ability of  infants to increase platelet production, as 
their megakaryocytes tend to be smaller and of  lower ploidy 
than those of  adults.20 Hypertension-induced foetal hypoxia 
is thought to have a direct depressant effect on megakaryocyte 
proliferation.21 The incidence of  thrombocytopenia is also 
known to decrease with increasing gestational age, explaining 
the higher incidence observed in a few other studies involving 
subjects delivered at an earlier gestational age.22 This study 
also corroborates the observation that gestational age is an 
independent determinant of  platelet count.
There was no significant difference in the mean haematocrit, 
absolute neutrophil count, or platelet count between the 
newborns of  women with various subtypes of  HIP, probably 
because fewer women (16%) had chronic hypertension, 
a subtype associated with the severest form of  placental 
insufficiency and hence more foetal manifestations.7 
Furthermore, the majority of  these women were on 
antihypertensive therapy, mitigating the effect of  high blood 
pressure on the placental circulation during the first half  of  
pregnancy.
Apart from the effect of  HIP on the haematological 
parameters of  neonates, this study also observed a lower 
mean birthweight in the case group than among controls, 
even after being matched for gestational age. However, the 
mean weight among cases was within the normal range. 
It was also observed that there was a higher incidence of  
operative delivery among women with HIP than in controls. 
Furthermore, there was no significant difference in the mean 
haematocrit, absolute neutrophil count, or platelet count 
among the various modes of  delivery.
Conclusions
This study, carried out in the Niger-Delta region of  Nigeria, 
has documented a significantly higher haematocrit with 
lower absolute neutrophil and platelet counts in neonates of  
women with HIP, compared to controls.
The study did not find any significant differences in the 
haematological profiles of  the neonates of  mothers with the 
various subtypes of  hypertension in pregnancy.
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